Last reviewed · How we verify
NCT04683055: PDT vs PT
Phaco-Trabeculotomy Vs Phaco-Trabeculectomy
NA trial testing Phacoemulsification combined with trabeculectomy in Ophthalmopathy in 50 participants. Completed in 1 May 2021.
31 December 2020
Quick facts
| Lead sponsor | Assiut University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 50 |
| Start date | 28 October 2020 |
| Primary completion | 31 December 2020 |
| Estimated completion | 1 May 2021 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- Phacoemulsification combined with trabeculectomy
- Phacoemulsificaiton combined with ab-externo trabeculotomy
Conditions studied
- Ophthalmopathy — all drugs for Ophthalmopathy →
- Glaucoma — all drugs for Glaucoma →
- Glaucoma, Angle-Closure — all drugs for Glaucoma, Angle-Closure →
Sponsor
Assiut University
Who can join
18 and older, any sex, with Ophthalmopathy or Glaucoma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A prospective, randomized comparative study on adult patients with synechial angle closure glaucoma.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Characteristics and publication status of minimally invasive glaucoma surgery trials registered in ClinicalTrials.gov, 2007-2024: a cross-sectional study.
Peng C, Jia H, Hu J, Jiao Y. · · 2025 · PMID 39855651 · DOI 10.1136/bmjopen-2024-095854
Verify or expand the search:
- PubMed search for NCT04683055
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Ophthalmopathy
Currently open trials in the same condition.
- NCT05414994 — Assessment of the Ocular Microbiome in Health and Disease · recruiting
- NCT06367517 — Tocilizumab in Corticosteroid-Resistant Graves' Orbitopathy (Thyroid Eye Disease) · recruiting
Other Assiut University trials
Trials by the same sponsor.
- NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
- NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
- NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
- NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
- NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04683055 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Assiut University
- Last refreshed: 29 October 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04683055.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing